Optomed PLC
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Optomed PLC
Optomed PLC is a Finnish medical technology company and a manufacturer of handheld fundus cameras and screening software. The company provides AI-based screening solutions to support diagnostic processes and early detection. It develops retinal imaging technology that is patented, clinically validated, and has approvals in all key markets, including CE, FDA and NMPA. The company's products are sold via various sales channels in over 60 countries. It has two reportable segments: Devices and Software. The majority of revenue is derived from the Software segment, which offers products for optimal management of various screening operations as well as IT solutions and services for storing, viewing and working with medical images. Geographically, it generates maximum revenue from Finland.
/ 
Others were interested in
Frequently asked questions
To buy Optomed PLC stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Optomed PLC by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Optomed PLC is OPTOMED:xhel. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Optomed PLC has its primary listing on NASDAQ OMX Helsinki. You can trade Optomed PLC with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Optomed PLC is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Optomed PLC as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Optomed PLC or others.